Back to Trades
Efron Paul
DirectorCIK 0002024711
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Efron Paul, Director, has filed 5 SEC reports (2025–2026), all concentrated in Keenova Therapeutics plc (NONE), totaling $710.0K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Jul 17 | NONE Keenova Therapeutics plc | Efron Paul | Director | Award | $0 |
| Jun 4 | NONE Keenova Therapeutics plc | Efron Paul | Director | Exercise | $0 |
| Feb 25 | NONE Keenova Therapeutics plc | Efron Paul | Director | Award | $0 |
| Aug 18 | NONE Mallinckrodt plc | Efron Paul | Director | Grant | $710.0K |
| Aug 4 | NONE Mallinckrodt plc | Efron Paul | Director | Other | $0 |
5 filings